✦ LIBER ✦

Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa

✍ Scribed by Audino Podda; Luciano Nencioni; Ilio Marsili; Samuele Peppoloni; Gianfranco Volpini; Donatella Donati; Annalisa Di Tommaso; Maria Teresa De Magistris; Rino Rappuoli

Book ID: 119151081
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 477 KB
Volume: 9
Category: Article
ISSN: 0264-410X
DOI: 10.1016/0264-410x(91)90290-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity of an acellular pertussis

Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children

✍ Audino Podda; Erminia Carapella^De Luca; Lucina Titone; Anna Maria Casadei; Anto 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Effect of priming with diphtheria and te

Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children

✍ Audino Podda; Gianni Bona; Gianpaolo Canciani; Anna Maria Casadei Pistilli; Brun 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 495 KB